StockNews.com began coverage on shares of Patterson Companies (NASDAQ:PDCO – Free Report) in a research report sent to investors on Friday. The brokerage issued a hold rating on the stock. A number of ...

Aurion Biotech, Inc. (Aurion), whose mission is to restore vision to millions of patients with life-changing regenerative ...

CFO updates stated that Roivant ended the quarter with $5.2 billion in cash and marketable securities, including $500 million authorized for additional share buybacks and $1 billion in stock ...

In what one analyst called a “unique situation,” the company stopped dosing patients on the recommendation of trial monitors, ...

In a report released today, Paul Matteis from Stifel Nicolaus maintained a Buy rating on Xenon (XENE – Research Report), with a price target of ...

In a report released today, Brandon Couillard from Wells Fargo maintained a Hold rating on Revvity (RVTY – Research Report), with a price ...

WALTHAM, Mass. - Q32 Bio Inc. (NASDAQ: QTTB), a clinical-stage biotechnology firm trading at $3.18 with a market cap of $38.55 million, announced a strategic shift to prioritize the development of its ...

Karen M. Anderson, Chief People Officer at Centessa Pharmaceuticals plc (NASDAQ:CNTA), recently sold shares amounting to a total of $588,943. The transactions occurred on February 7 and February 10, ...

Spire Wealth Management bought a new position in Tenaya Therapeutics, Inc. (NASDAQ:TNYA – Free Report) in the fourth quarter, ...

In the assessment of 12-month price targets, analysts unveil insights for 4D Molecular Therapeutics, presenting an average ...